logo
The three reasons to doubt Letby convictions over attempted baby deaths

The three reasons to doubt Letby convictions over attempted baby deaths

Telegraph14 hours ago
When Lucy Letby was questioned during her trial about how two babies came to have dangerously low blood sugar, even she accepted that they must have been poisoned with insulin.
Blood test results appeared to show the insulin levels in the babies were not natural, suggesting the hormone could only have been administered externally.
Now experts are casting doubt not only on whether Letby was guilty, but whether extra insulin was ever given to the babies at all.
Prof Geoff Chase and Helen Shannon, a chemical engineer, have written an extensive 173-page report for Letby's defence team, which has been submitted to the Criminal Cases Review Commission (CCRC), the body that examines potential miscarriages of justice.
'I am happy to show up in court, or to the CCRC, or the Crown Prosecution Service, and go through it with them line-by-line,' said Prof Chase, a specialist in insulin delivery to critically ill adults and neonates, and author of over 650 journal articles, from the University of Canterbury in Christchurch, New Zealand.
Here, they set out their arguments to The Telegraph.
The missing insulin
Letby was convicted of injecting insulin into the feed bags of two babies known as Child F and Child L at the Countess of Chester Hospital in 2015 and 2016.
Both had suffered alarming crashes in blood sugar, and medical staff were sufficiently concerned to send blood samples to a laboratory in Liverpool for analysis.
The lab flagged an anomaly in both cases. When the body creates insulin naturally, it also produces the same amount of a second hormone, called c-peptide, which breaks down at an equal rate.
Because insulin leaves the body much faster than c-peptide, there should have been far less of it – but in the case of Child F, the lab found the reverse. Tests showed high insulin but low c-peptide.
Child L also had relatively high insulin levels, and both cases suggested extra insulin had been administered accidentally or, as the prosecution would claim, maliciously.
Both babies recovered before the tests returned, so the hospital filed away the reports, which were not found until detectives began hunting for evidence and noticed that the incidents coincided with Letby's shift patterns.
During Letby's trial, Prof Peter Hindmarsh, an endocrinologist from University College London (UCL), calculated that just a drop (0.6ml) of insulin needed to be added to feed bags to cause the crashes.
But Prof Chase and Ms Shannon disagree. According to them, it would require at least 10 times as much (6ml) to produce the same effect – nearly two thirds of a vial of insulin. This is because insulin is 'sticky', holding on to surfaces rather than being pumped into the body.
They calculate it could even require up to six to seven vials, which would have been noticed by hospital staff. Yet no insulin was ever found to be missing.
'Insulin sticks, or technically adsorbs, to many surfaces and particularly plastics used in the bags delivering nutrition as well as the lines and cannulas,' said Ms Shannon.
'The trial stated no insulin was missing and it would require only a very small drop. If injected intravenously yes, this is true, but with adsorption, or sticking, it would require between 1.2 teaspoons to six to seven vials.
'Simply, there was no possibility to commit insulin poisoning as hypothesised in court.'
Letby's trial heard that just three vials of insulin were issued to the neo-natal unit in 2014, six vials in 2015 and two vials in 2016 and were kept in a locked fridge in an equipment room.
Prof Chase added: 'If no insulin is missing, there is no way to commit that crime. Insulin sticking to lines, bags, tubes is a known thing and it can significantly impact, for example, insulin pump use among small children. The lack of missing insulin is the true smoking gun in this case.'
The problem with antibodies
Even if there was no missing insulin, it still does not explain why the lab readings for Child F and Child L looked so worrying.
At Letby's trial, Dr Anna Milan, a biochemist at the Liverpool lab, told the court that 'the only way you can get a pattern like that is if there's insulin [that has] been given to a patient'.
Prof Chase and Ms Shannon dispute this. They argue that babies are often born with antibodies that bind with insulin, effectively storing the hormone in the body for much longer than normal, and raising levels 'beyond expectation'.
Studies have shown that between three and 97 per cent of preterm infants are born with such antibodies, and it is even more likely if they have been exposed to infections and some antibiotics.
In the case of the Letby babies, both had been treated with antibiotics for suspected sepsis, and the neo-natal unit had been struggling to get rid of a bacterium – Pseudomonas aeruginosa – which had colonised taps.
The unit was also having a problem with sewage leaking from pipes in the ceiling, and had been forced to put nappy pads in the roof cavity to soak up the waste. The risk of infection in the unit was high.
'When a neonate or its mother is exposed to infective agents, or certain antibiotics, insulin levels can be sky high,' Prof Chase added. 'When an insulin antibody binds to insulin, what happens is it stays in the blood, and it stores it, and it'll stay there for days, to weeks, to months. In one published case study it took a year for bound insulin to disappear.'
The antibody problem is well known, and the lab should have sent the sample away for further testing but that never happened.
'If you go to a variety of online NHS guidelines around insulin and c-peptide testing they will tell you that if you get a very high insulin rating, you should test again, and they'll also tell you to test for antibodies,' said Prof Chase. 'But that was never done because [the result] wasn't important to people at the time.'
An NHS guidance note from the Liverpool lab warned that the Roche assay used could not determine whether insulin had been artificially administered and advised sending it to a forensic lab
But samples were never checked by forensic experts and the defence was not able to re-test the blood. It had already been thrown away.
Preterm anomalies
The prosecution's case was that the high levels of insulin and low c-peptide indicated foul play.
In the trial, it was stated that a healthy insulin to c-peptide ratio should be between 1:10 and 1:20. In other words, there should be 10 to 20 times more c-peptide than insulin.
In the case of Child F, that ratio was flipped, with insulin levels of 4,657 and a very low c-peptide level of less than 169.
But Prof Chase and Ms Shannon said the trial experts were relying on data from older children or adults, and that newborn and preterm babies often have strikingly different hormone ratios.
In fact, the c-peptide levels for all the infants were well within reported ranges for neonates in published studies.
One paper, which looked at 76 sets of assays from preterm infants, showed more than over 40 per cent had hormone levels that were equal or even reversed, with insulin higher than c-peptide.
And their new modelling showed that when antibody binding was added into the mix, insulin levels could rise up to 10,000.
Prof Chase said: 'Normally insulin and c-peptide come out in equal amounts. C-peptide goes up into a bucket with one hole, insulin goes into a bucket with three holes.
'But if insulin also binds with antibodies and goes into a bucket with no holes, the relative levels can change and measured insulin levels build up over time. And once you have antibodies, you can get almost any number you want in relatively short order.'
Ms Shannon added: 'If you've got these infective agents in the mix, and when you've got insulin binding reactions going on, virtually any neonate would react in the way these neonates did.'
'Critically, the Roche assay used measures this bound insulin, which is why retesting for antibodies or more specific tests are required to determine insulin poisoning.'
The pair also argue that it is not uncommon for preterm babies to develop low blood sugar, particularly if they are critically ill. Research shows that around one in three such infants suffer very low blood glucose levels and up to half are not responsive to glucose.
'No way to prove a crime occurred'
Even during the trial opening, Nicholas Johnson KC admitted the insulin anomalies were originally 'attributed to a naturally occurring phenomenon'.
Ms Shannon added: 'There is no way to prove a crime occurred and there is ample evidence to suggest non-malicious interpretation of the assay results.'
The assays themselves are also not foolproof, with up to four per cent giving misleading or unreliable results.
The lab that tested the samples underwent an assessment a few weeks after Child L's test, which found it exaggerated the level of insulin in a quality control sample by almost 800 per cent.
Prof Chase added: 'None of this is hard to find. But seemingly it didn't cross anyone's minds to check with 15 life sentences on the line.'
The police and Crown Prosecution Service said there was a wealth of evidence, and testimony from medical experts, to convict Letby, and are considering bringing new charges against the nurse. The Liverpool lab is also standing by its findings.
Meanwhile, the CCRC is deciding whether to send Letby's case back to the Court of Appeal, with a decision expected before Christmas.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A&E waits fuel 4,000 attacks on NHS staff a year: One worker is attacked every two hours in 'tinder box' hospitals as nurses face violence and gun threats
A&E waits fuel 4,000 attacks on NHS staff a year: One worker is attacked every two hours in 'tinder box' hospitals as nurses face violence and gun threats

Daily Mail​

time26 minutes ago

  • Daily Mail​

A&E waits fuel 4,000 attacks on NHS staff a year: One worker is attacked every two hours in 'tinder box' hospitals as nurses face violence and gun threats

NHS staff are facing 'utterly abhorrent' levels of violence in A&E – with one worker attacked every two hours, damning figures reveal today. Middle-class patients and their families are among those driven to rage by long waits and dehumanising care in corridors, the Royal College of Nursing said. It warned that its members were physically and mentally scarred after being punched, spat at – and even threatened with guns. Many have been forced to take time off to recover, with some too traumatised to return. The nurses' union warned that the Government's ten-year plan to reform the Health Service will 'fail completely' without action to protect and retain staff. In all, 89 hospital trusts responded to a Freedom of Information request from the RCN, revealing that they recorded 4,054 reports of physical violence against A&E staff last year – almost double the 2,093 in 2019. It means 11 members of A&E staff are attacked on average every day in England. However, the true figure is likely to be even higher as just 69 per cent of NHS acute trusts responded to the RCN, and they were only asked for figures for their biggest A&E. Meanwhile, a separate analysis by the RCN shows that incidents of patients having to wait more than 12 hours in A&E increased 20-fold between 2019 and 2024. The news comes as: Nine in ten pharmacies are victims of shoplifting, with strong painkillers among the drugs being targeted. Victims' minister Alex Davies-Jones admitted shoplifting had 'got out of hand' after police ordered a store to remove a sign calling thieves 'scumbags'. Sarah Pochin, Reform UK's only female MP, said it was 'no surprise' that vigilante groups were patrolling the streets as immigration led to fears for women's safety. Rachelle McCarthy, a senior charge nurse from the East Midlands, was punched 'square in the face' by a 'drunk, 6ft 2in bloke'. She said: 'Even patients you would expect to be placid are becoming irate because of just how long they have to wait. You can only imagine the behaviour of those who are already prone to violence.' A senior A&E nurse based in east London said her hospital was a 'tinder box' for violence. She has seen colleagues punched, kicked and had a gun pointed at them, while she had been spat at by a patient and threatened with an acid attack. She said she became depressed and anxious and took a research role to take a break from nursing, adding: 'The violence I saw made me become more fearful outside work. I saw how volatile people can be.' Sarah Pochin (pictured), Reform UK's only female MP, said it was 'no surprise' that vigilante groups were patrolling the streets as immigration led to fears for women's safety A senior A&E nurse in the South West said a patient 'pinned a nurse up against a wall' and another punched a member of staff 'in the groin and stomach'. She added: 'It's not going to help with our retention and recruitment if you think you're going to be clobbered every shift.' Sarah Tappy, a senior A&E sister in east London, was punched in the head and knocked unconscious by a patient, leaving her with anxiety and PTSD. 'The violence is awful,' she said. 'And it's just constant. None of us feel safe.' At Maidstone Hospital in Kent, incidents rose by more than 500 per cent, from 13 in 2019 to 89 in 2024, while at Manchester Royal Infirmary, attacks rose from 39 to 79. In April, Health Secretary Wes Streeting pledged to 'keep NHS staff safe' by implementing mandatory hospital-level reporting of violence against staff, saying that 'protecting staff from violence is not an optional extra'. However, the RCN says the Government 'needs to do more than just record the shocking levels of violence'. Professor Nicola Ranger, RCN general secretary, said: 'Behind these shocking figures lies an ugly truth. Dedicated and hard-working staff face rising attacks because of systemic failures that are no fault of their own. Nursing staff not only go to work underpaid and undervalued but face a rising tide of violence. It leads to physical and mental scarring, lengthy time off and sometimes staff never returning. 'You can't fix the Health Service when vital staff are too scared to go into work. 'Unless the Government does something about lengthy waits, corridor care and understaffed nursing teams, more staff will become victims of this utterly abhorrent behaviour. Left unaddressed, this could see plans to reform the NHS fail.' Daniel Elkeles, chief executive of NHS Providers, which represents trusts said: 'These findings are absolutely shocking.' Rebecca Smith, of NHS Employers, said: 'No one should have to face violence at work – it is totally unacceptable.' Mr Streeting said: 'I am appalled. Nurses dedicate their lives to helping others and deserve to go about their jobs free from violence. Anyone who violates this core principle will feel the full force of the law.'

Annual Perseid meteor shower to reach dazzling peak on Tuesday night
Annual Perseid meteor shower to reach dazzling peak on Tuesday night

The Independent

timean hour ago

  • The Independent

Annual Perseid meteor shower to reach dazzling peak on Tuesday night

Shooting stars will be visible across the UK in the annual Perseid meteor shower that reaches its dazzling peak on Tuesday night. Every summer the Earth slams into a trail of debris from the Swift-Tuttle comet that also orbits the Sun. Specks as small as a grain of dust or rice flare up under the pressure of the planet's atmosphere to create shooting stars, said Royal Observatory Greenwich astronomer Dr Ed Bloomer. Around 150 meteors will cross the sky per hour but that amount will not be visible because the horizon blocks a full view of the sky, he added. However, an estimated 100 meteors could be seen per hour in certain locations that are particularly flat and dark. The meteor shower has been running for a few weeks and will continue until around August 24, the astronomer told the PA news agency. He said this means that 'we have lots of chances to see this' but 'you have to let your eyes adjust to the dark'. Dr Bloomer recommended stargazers wait half an hour to let their eyes get used to it, adding: 'Take a camping chair or something – if you had one, you would just sit down, and you would just relax, and you would just wait. 'You want to get away from city lights, you want to get away from street lamps. 'If you're looking out from your garden – it sounds obvious – but switch the kitchen light off, give yourself time to just put the phone away.' People struggling to see the meteors can turn and watch through their peripheral vision as it is 'a little bit better with low light conditions', he said. As it is summer, viewers will also have to wait until relatively late at night for it to be dark enough to see the celestial show. The astronomer added: 'For us, it's kind of one of the best (meteor showers), it's kind of reliable, it's long lived, it's quite dense… it's pretty active. 'You don't need to really be in a very specific location, the hourly rate is fairly high, so I think even beginners will be I think satisfied having seen them.' The weather is largely clear but early in the week the almost-full waning moon could make Perseid less visible. The meteor shower will be in the north-east as the sun is going down, Dr Bloomer added. He said: 'However, it's not available to everybody, because the further south you go… Perseid is lower and lower on the horizon. 'The primary interest is for Northern Hemisphere observers – Perseid is pretty low for us here in the UK, but it is above the horizon… in fact, it's above the horizon all day, but the problem is, of course, during the day, nothing's going to be visible.' Despite it being more visible in the north 'the dominant thing is going to be, can you get yourself in a dark location', he added. 'Getting into the middle of a field in the south east of England, in London, is going to be better than being in the middle of Aberdeen.' Shooting stars generally only last a second or two and sometimes appear in flurries, the astronomer said. Rarer meteors the size of a fist or basketball will produce longer tails and are known as fireballs, he added. These can last five to 10 seconds, but Dr Bloomer said he has only ever seen one. The level up is a bolide but 'that's a sort of national emergency type thing', he added.

How our 'killer' immune cells can be harnessed to beat diabetes and arthritis
How our 'killer' immune cells can be harnessed to beat diabetes and arthritis

Daily Mail​

timean hour ago

  • Daily Mail​

How our 'killer' immune cells can be harnessed to beat diabetes and arthritis

A 'game changing' new technique which wipes out rogue cells responsible for autoimmune conditions may offer the hope of a one-off treatment for many debilitating diseases. Around four million people in the UK live with an autoimmune condition, according to a major study published in The Lancet. These arise when immune cells produce faulty antibodies that mistakenly attack the body's own tissues, triggering inflammation and tissue damage. Depending on the condition, different parts of the body are affected. In rheumatoid arthritis, for example, it's mainly the joints, with type 1 diabetes it is cells in the pancreas that produce insulin, and in multiple sclerosis, it's the nerves, leading to numbness and movement difficulties. The new treatment harnesses the body's own immune defenders, 'natural killer' cells, to wipe out rogue white blood cells responsible for producing the antibodies that launch these attacks. Early trials show it not only improves symptoms, but 'resets' the immune system, suggesting it may offer long-lasting relief. Current treatment for autoimmune conditions often relies on long-term use of steroids and immunosuppressant drugs, but in reducing the immune response these can increase risk of infection, cancer and other complications. In the absence of effective treatments many patients face years of fatigue, pain and disability. More recently, scientists have begun trialling CAR-T therapy, better known as a cutting-edge cancer treatment, for autoimmune diseases such as lupus – where multiple tissues and organs come under attack, including the kidneys, lungs, joints and brain. CAR-T therapy works by modifying a type of white blood cell called T cells so they recognise a marker on the cancer cell and then kill it. While promising, 'one drawback to this approach is there can be significant side-effects', says Professor Lucy Walker, chair in immune regulation at the Institute of Immunity & Transplantation, University College London. These include cytokine release syndrome, where the immune system goes into dangerous over-drive, triggering widespread inflammation, and neurological complications. 'While these may be acceptable in cancer settings, as late-stage cancer patients tend to be older, for autoimmune diseases, approaches with fewer side-effects are needed because they're chronic but not immediately life-threatening and often affect younger people,' she adds. It's hoped the latest breakthrough (called CAR NK –which stands for Chimeric Antigen Receptor Natural Killer cells) may prove an even better option. The CAR NK cells are a type of immune cell genetically engineered in the lab to target the cells that produce the faulty antibodies. The immune system then regenerates with 'normal' cells. The difference with CAR-T therapy, says Professor Walker, is that with the newer technique the 'CAR' (an artificial protein that helps immune cells attack specific targets) is put in 'another type of white blood cell, the NK cell, in order to deliver the same killing effect, but with fewer toxicities'. And while CAR-T cells must be made from the patient's own immune cells in a complex and time-consuming process, CAR NK cells can be manufactured in bulk from donor umbilical cord blood or stem cells, then frozen and stored ready for use, significantly reducing cost. The treatment is already being tested on patients with lupus, a condition affecting around 70,000 people in the UK and which can be debilitating, even life-threatening. After 27 people with severe lupus received an infusion of CAR NK cell therapy, all showed signs of improvement and 70 per cent went into full remission, according to results presented in June at a major rheumatology conference in Barcelona. What's more, there were no reports of serious side-effects. In another study, published in Cell in June, researchers treated a patient with systemic sclerosis, a rare and serious autoimmune disease that attacks blood vessels and connective tissue, leading to organ damage. After treatment, the patient's skin and blood vessels began returning to normal. One benefit of using natural killer cells is they do not usually trigger rejection, so there is no need for a tissue match. Professor Zhao Dongbao, a senior immunotherapy researcher at Shanghai's Naval Medical University and one of the lead investigators on the lupus study, told Good Health CAR NK therapy 'is expected to be used for the treatment of more than ten million patients worldwide, with more than one million patients with autoimmune diseases in the US and the UK'. He says plans are under way for formal clinical trials for lupus, 'with potential expansion to other autoimmune diseases in the future'. He believes the approach could 'transform care' for people with a wide range of autoimmune conditions. But Professor Walker cautions: 'The approach is promising but is in its infancy – it's only been tested on a very small number of people.' However, she says, if follow-up work 'showed it was successful, it could represent a much more targeted approach than long-term immunosuppression and potentially be tolerated much better'. Luke Evnin, chair of the US-based Scleroderma Research Foundation, is upbeat: 'The promise is that in a single course of treatment, the patient would get lasting benefit and potentially stop other medicines and be freed from disease progression. It would be a game-changer.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store